KEY PRODUCTS
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG
01 1TRIPTORELIN PAMOATE
01 1Switzerland
01 1Active
01 1Blank
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6291
Submission : 1986-04-25
Status : Active
Type : II
20
Bachem Ag, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
One of their notable products is TRIPTORELIN PAMOATE, with a corresponding US DMF Number 6291.
Remarkably, this DMF maintains an Active status since its submission on April 25, 1986, highlighting commitment to regulatory compliance.
